Hearne Michael S bought AUPH
May 18, 2026 · Form 4 insider transaction
Hearne Michael S bought 70,230 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
70,230
Price
$0.00
Total value
N/A
InsiderHearne Michael S
Role—
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMay 18, 2026
Filing dateMay 20, 2026
Shares owned after70,230
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.